-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Maintains Buy on Innoviva, Raises Price Target to $46

Benzinga·12/16/2025 12:00:53
语音播报
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $45 to $46.